The Iranian Journal of Obstetrics, Gynecology and Infertility

The Iranian Journal of Obstetrics, Gynecology and Infertility

Effect of Pethidine (Meperidine) on decreasing the duration of First and Second Stages of Labor

Document Type : Original Article

Authors
Fatemeh Lalooha 1
Ameneh Barikani 2
Narjes-Beygom Hashemian 3
Neda Esmailzadehha 4
1 Associate Professor, Department of Obstetrics and Gynecology, Children Growth Research Center, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
2 Associate Professor, Department of Community Medicine, Children Growth Research Center, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
3 Gynecologist, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
4 General practitioner, Metabolic Diseases Research Center, Faculty of Medicine, Qazvin University of Medical Sciences, Qazvin, Iran.
10.22038/ijogi.2017.8415
Abstract
Introduction: Pethedine is used to decrease labor pain. According to some studies, pethidine can be effective on labor progress. This study was performed with aim to determine the effect of pethidine on decreasing the duration of the first and second stages of labor.
Methods: This clinical trial was performed on 120 nulliparous women with term singleton pregnancy who needed induction of labor for pregnancy termination in Kosar hospital, Qazvin in 2013. They were randomly assigned in two groups of intervention and control (n=60). A single dose of 50 mg pethidine was injected intravenously at 4 cm cervical dilatation in intervention group. In control group, normal saline was injected as placebo. The intervals between the injection and complete cervical dilatation, the complete cervical dilatation and the end of delivery, and the injection and the end of delivery were measured. Data were analyzed by SPSS software (version 19) and student T-test and Chi-square test P< 0.05 was considered significant.
Results: The mean interval between the injection of pethedine and complete cervical dilatation was 129±70 min in intervention group and 133±75 min in control group and the difference was not statistically significant (P=0.7). The mean duration of second stage of labor was 45±26 min in intervention group and 41±16 min in control group and the difference was not statistically significant (P=0.3). The mean interval between pethidine injection and end of delivery was 175±79 min in intervention group and 174±83 min in control group and the difference was not statistically significant (P=0.39).
Conclusions: There is no significant relationship between pethidine injection and progression of the labor stages.
Keywords
Delivery
First Labor Stage
Meperidine
Second Labor Stage
  1. ACOG Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin No. 80: premature rupture of membranes. Clinical management guidelines for obstetrician-gynecologists. Obstet Gynecol 2007; 109(4):1007-19.
  2. Cunningham FG, Leveno KJ, Bloom SL, Hauth JC, Rouse DJ, Spong CY. Williams obstetrics. 23rd ed. New York: McGraw-Hill; 2010.
  3. American College of Obstetrics and Gynecology Committee on Practice Bulletins-Obstetrics. ACOG Practice Bulletin Number 49, December 2003: Dystocia and augmentation of labor. Obstet Gynecol 2003; 102(6):1445-54.
  4. Yilmaz B, Kart C, Kelekci S, Gokturk U, Sut N, Tarlan N, et al. Meperidine versus valethamate bromide in shortening the duration of active labor. Int J Gynaecol Obstet 2009; 107(2):126-9.
  5. El-Refaie TA, El-Said MM, Shoukry AA, Khafagy SM, El-Din AS, Badawy MM. Meperidine for uterine dystocia and its effect on duration of labor and neonatal acid-base status: a randomized clinical trial. J Obstet Gynaecol Res 2012; 38(2):383-9.
  6. Sosa CG, Balaguer E, Alonso JG, Panizza R, Laborde A, Berrondo C. Meperidine for dystocia during the first stage of labor: a randomized controlled trial. Am J Obstet Gynecol 2004; 191(4):1212-8.
  7. Brunton LL. Goodman and Gilman´S the pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill; 2010. P. 549.
  8. Kaiko RF, Foley KM, Grabinski PY, Heidrich G, Rogers AG, Inturrisi CE, et al. Central nervous system excitatory effects of meperidine in cancer patients. Ann Neurol 1983; 13(2):180-5.
  9. Wagner LE 2nd, Eaton M, Sabnis SS, Gingrich KJ. Meperidine and lidocaine block of recombinant voltage-dependent Na+ channels: evidence that meperidine is a local anesthetic. Anesthesiology 1999; 91(5):1481-90.
  10. Donna Wong (2002-03-15). Notes on Meperidine. Wong on Web Papers. Elsevier. Available at: URL: http://www.mosbysdrugconsult.com/. WOW/op024.html; 2007.
  11. Walker DJ, Zachy JP. Subjective, psychomotor, and physiological effects of cumulative doses of opioid mu agonists in healthy volunteers. J Pharmacol Exp Ther 1999; 289(3):1454-64.
  12. Brody Jane. A mix of medicines that can be lethal. New York: New York Times; 2007.
  13. Baselt RC, Cravey RH. Disposition of toxic drugs and chemicals in man. 8th ed. Foster City: CA: Biomedical Publications; 2009. P. 911-4.
  14. Boehringer Ingelheim Pharmaceuticals, Inc. Ridgefield, CT: Aptivus (Tipranavir) Package Insert; 2005.
  15. Mansoori S, Adams S, Cheater FM. Choice of analgesia in labour on neonatal outcomes, delivery and maternal satisfaction with pain relief. Clin Effect Nurs 2000; 4(1):11–9.
  16. Kamyabi Z, Zamiri Z, Ramezani A. Effect of pethidine on the duration of stages of labour. J Qazvin Univ Med Sci 2003; 7(3):23-8. (Persian).
  17. Direkvand-Moghadam A, Delpisheh A, Rezaeian M, Khosravi A. Factors affecting the labor: a review article. Biomed Pharmacol J 2013; 6(2):161-7.
  18. Terkawi AS, Wani TM, Al-Shuaibi KM, Tobias JD. Anesthetic considerations in Leigh disease: case report and literature review. Saudi J Anaesth 2012; 6(2):181-5.
  19. Crafter H. Physiology of pain in normal labour. In: Yerby M, editor. Pain in childbearing: key issues in management. Philadelphia: Elsevier Health Sciences; 2000. P. 43-60.
  20. Khooshideh M, Shahriari A. A comparison of tramadol and pethidine analgesia on the duration of labour: a randomized clinical trial. Aust N Z J Obstet Gynaecol 2009; 49(1):59-63. 
The Iranian Journal of Obstetrics, Gynecology and Infertility
Volume 19, Issue 39
February 2017
Pages 1-7